Skip to main
University-wide Navigation

Markey Launching New Summer Oncology Program for Teen Girls

The Summer HealthCare Experience (SHE) in Oncology program, is aimed at empowering high school girls throughout Kentucky to learn more about the field of cancer medicine and research. The inaugural program will be held July 12-23 and will be virtual due to the ongoing pandemic.

Drug Derived from Kentucky-Grown Plant Shows Promise for Ovarian Cancer Treatment

Kentucky is the only state currently growing substantial quantities of Artemisia annua, meaning the Commonwealth could become a new epicenter for growing the plant worldwide. The plant’s growth could potentially give Kentucky’s farmers a new cash crop to supplement income. 

UK Undergrads Earn Unparalleled Research Experience as ‘First Authors’

Many undergraduates participate in research alongside UK’s world-class faculty. This high impact learning experience allows undergraduates to explore career options and set themselves apart for graduate or professional school or employment.

DREAM Program Expands Community, Career Development for Health Equity Researchers from Underrepresented Minorities

The program has supported the training of underrepresented pre-docs, post-docs and assistant professors at the University of Kentucky committed to health equity research.

Markey Joins Nationwide Effort to Encourage Resumption of Cancer Screening, Treatment

The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Williams Named Assistant Director for Cancer Health Equity at Markey

A major initiative of Williams and the Markey Community Impact Office will be the organization and expansion of Markey’s research and outreach portfolio that is focused on reducing cancer and other health disparities based on race/ethnicity, socioeconomic status, etc.

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

UK Study Highlights Need for Genetic Testing for Kentucky Patients with Lung Cancer

Recently published in PLOS One, the study used Kentucky Cancer Registry patient data from 2007-2011 to identify trends in epidermal growth factor receptor (EGFR) mutation testing and the usage of the EGFR inhibitor, erlotinib.

Markey Joins National Cancer Consortium to Address the Impact of COVID-19 on Cancer

Markey has joined a consortium of 17 cancer centers across the country to better understand how COVID-19 has impacted cancer prevention, detection and care.